PDF herunterladen
Horm Metab Res 2013; 45(04): 255-256
DOI: 10.1055/s-0033-1341495
Editorial
© Georg Thieme Verlag KG Stuttgart · New York

Acromegaly and Oxidative Stress: Impact on Endothelial Dysfunction and Atherosclerosis

H. Morawietz
1   Department of Medicine III, Division of Vascular Endothelium and Microcirculation, University of Technology Dresden, Dresden, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 14. März 2013

accepted 14. März 2013

Publikationsdatum:
22. April 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Key words

acromegaly - antioxidative capacity - cardiovascular diseases - endothelial dysfunction - nitric oxide - oxidative stress
 

  • References

  • 1 Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest 2009; 119: 3189-3202
    CrossrefPubMedGoogle Scholar
  • 2 Paisley AN, Izzard AS, Gemmell I, Cruickshank K, Trainer PJ, Heagerty AM. Small vessel remodeling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries from patients with acromegaly. J Clin Endocrinol Metab 2009; 94: 1111-1117
    CrossrefPubMedGoogle Scholar
  • 3 Lombardi G, Di Somma C, Grasso LF, Savanelli MC, Colao A, Pivonello R. The cardiovascular system in growth hormone excess and growth hormone deficiency. J Endocrinol Invest 2012; 35: 1021-1029
    PubMedGoogle Scholar
  • 4 Muller G, Morawietz H. Nitric oxide, NAD(P)H oxidase, and atherosclerosis. Antioxid Redox Signal 2009; 11: 1711-1731
    CrossrefPubMedGoogle Scholar
  • 5 Boero L, Cuniberti L, Magnani N, Manavela M, Yapur V, Bustos M, Gomez Rosso L, Merono T, Marziali L, Viale L, Evelson P, Negri G, Brites F. Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly. Clin Endocrinol (Oxf) 2010; 72: 654-660
    CrossrefPubMedGoogle Scholar
  • 6 Yarman S, Ozden TA, Gokkusu C. The evaluation of lipid peroxidation and acute effect of octreotide on lipid peroxidation in patients with active acromegaly. Clin Chim Acta 2003; 336: 45-48
    CrossrefPubMedGoogle Scholar
  • 7 Anagnostis P, Efstathiadou ZA, Gougoura S, Polyzos SA, Karathanasi E, Dritsa P, Kita M, Koukoulis GN. Oxidative Stress and Reduced Antioxidative Status, along with Endothelial Dysfunction in Acromegaly. Horm Metab Res 2013; [Epub ahead of print]
    PubMedGoogle Scholar
  • 8 Morawietz H. Endothelial NADPH oxidases: friends or foes?. Basic Res Cardiol 2011; 106: 521-525
    CrossrefPubMedGoogle Scholar
  • 9 Muller G, Morawietz H. NAD(P)H oxidase and endothelial dysfunction. Horm Metab Res 2009; 41: 152-158
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 10 Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175-2183
    CrossrefPubMedGoogle Scholar
  • 11 Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, Drummond GR. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol 2010; 298: H24-H32
    CrossrefPubMedGoogle Scholar
  • 12 Schramm A, Matusik P, Osmenda G, Guzik TJ. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 2012; 56: 216-231
    CrossrefPubMedGoogle Scholar
  • 13 Kampfrath T, Maiseyeu A, Ying Z, Shah Z, Deiuliis JA, Xu X, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun Q, Morawietz H, Rajagopalan S. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res 2011; 108: 716-726
    CrossrefPubMedGoogle Scholar
  • 14 Olivares-Corichi IM, Viquez MJ, Gutierrez-Lopez L, Ceballos-Reyes GM, Garcia-Sanchez JR. Oxidative stress present in the blood from obese patients modifies the structure and function of insulin. Horm Metab Res 2011; 43: 748-753
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Taye A, Saad AH, Kumar AH, Morawietz H. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol 2010; 627: 42-48
    CrossrefPubMedGoogle Scholar
  • 16 Seiva FR, Berbert CM, Souza GA, Rocha KK, Ebaid GM, Burneiko RC, Novelli EL. Energy expenditure, lipid profile, oxidative stress, and cardiac energy metabolism after growth hormone treatment in obese young rats. Horm Metab Res 2010; 42: 496-501
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 17 Seiva FR, Chuffa LG, Ebaid GM, Silva T, Fernandes AA, Novelli EL. Calorimetry, morphometry, oxidative stress, and cardiac metabolic response to growth hormone treatment in obese and aged rats. Horm Metab Res 2011; 43: 397-403
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 18 Tada Y, Yano S, Yamaguchi T, Okazaki K, Ogawa N, Morita M, Sugimoto T. Advanced Glycation End Products-induced Vascular Calcification is Mediated by Oxidative Stress: Functional Roles of NAD(P)H-oxidase. Horm Metab Res 2013; [Epub ahead of print]
    PubMedGoogle Scholar
  • 19 Jimenez C, Ayala-Ramirez M, Liu J, Nunez R, Gagel RF. Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegaly. Horm Metab Res 2011; 43: 55-61
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 20 Jialal I, Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 2003; 107: 926-928
    CrossrefPubMedGoogle Scholar